Compared with Scenario 7 and Scenario 10, ICERs of Scenario 16 were both greater than zero, which meant that Scenario 16 could reduce AI and TC, and be more cost-effective due to implementing an additional NAT on the NSD with infections and increasing NAT frequency of CRP. The gene discussed is BRD2; the disease is infection.